Transport
Maury Regional Hospital
Maury Regional Hospital was paid $24.53M by Medicaid between Jan 2018 and Dec 2024, across 123 billing codes. Its largest line is 99284, emergency room visit (serious) — 33% of everything it billed.
33Billing provider infoMAURY REGIONAL HOSPITAL
COLUMBIA, TN 38401
COLUMBIA, TN 38401
33aNPI1861479545assigned 12/23/2005
33bProvider typeLand Ambulance
28Total paid$24.53M
24GClaims394,352
24DCodes billed123
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Land Ambulance providers in Tennessee
Rank by total paid#2 of 98
Median peer was paid$1.20M
This provider vs. median20×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 62,563 | $3.89M | |
| 2019 | 65,306 | $3.77M | |
| 2020 | 46,500 | $2.92M | |
| 2021 | 56,369 | $3.68M | |
| 2022 | 53,107 | $3.69M | |
| 2023 | 67,100 | $4.01M | |
| 2024incomplete | 43,407 | $2.57M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 33% | 32,936 | 30,047 | $8.01M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 30,237 | 28,376 | $5.80M |
| A0425 | Ground mileage, per statute mile | 9.7% | 37,223 | 25,697 | $2.37M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.2% | 8,249 | 7,325 | $1.78M |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 5.5% | 14,418 | 12,151 | $1.35M |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 2.9% | 8,305 | 6,991 | $713K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.6% | 5,924 | 5,574 | $635K |
| 59025 | Fetal non-stress test | 1.7% | 4,979 | 2,633 | $427K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.7% | 3,577 | 3,398 | $424K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.5% | 11,760 | 7,676 | $359K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.1% | 4,682 | 1,478 | $258K |
| G0378 | Hospital observation service, per hour | <1% | 1,002 | 862 | $220K |
111 more codes
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 3,403 | $178K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,128 | $173K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 15,487 | $162K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 39,649 | $142K |
| 64493 | <1% | 419 | $132K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 449 | $128K |
| 80053 | Comprehensive metabolic panel | <1% | 43,125 | $110K |
| 43235 | <1% | 608 | $87K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,401 | $67K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 983 | $66K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 9,004 | $65K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 351 | $56K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,591 | $46K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 12,291 | $44K |
| 43450 | <1% | 561 | $43K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 128 | $43K |
| 64495 | <1% | 459 | $36K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 12,439 | $32K |
| 64494 | <1% | 472 | $32K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | <1% | 97 | $32K |
| 84484 | <1% | 3,444 | $31K | |
| 87631 | <1% | 600 | $30K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,723 | $30K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 6,703 | $27K |
| 97597 | <1% | 1,358 | $27K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,396 | $23K |
| 71250 | <1% | 670 | $23K | |
| 96367 | <1% | 795 | $19K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 333 | $19K |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | <1% | 68 | $17K |
| 82803 | <1% | 1,990 | $17K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,740 | $17K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,497 | $16K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 70 | $16K |
| 83690 | <1% | 3,872 | $14K | |
| 77334 | <1% | 98 | $14K | |
| 77336 | <1% | 615 | $14K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,129 | $14K |
| 71045 | Radiologic examination, chest; single view | <1% | 7,421 | $13K |
| 87428 | <1% | 270 | $12K | |
| 83605 | <1% | 2,215 | $10K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 30 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,854 | $9K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 224 | $8K |
| A0433 | Advanced life support, level 2 (als 2) | <1% | 42 | $7K |
| 87430 | <1% | 1,237 | $7K | |
| 77300 | <1% | 106 | $7K | |
| 95816 | <1% | 85 | $6K | |
| 81003 | <1% | 11,857 | $6K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 51 | $5K |
| 81001 | <1% | 7,268 | $5K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 177 | $4K |
| 76830 | Ultrasound, transvaginal | <1% | 71 | $4K |
| 87081 | <1% | 952 | $4K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 28 | $4K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 13 | $3K |
| 81025 | <1% | 1,229 | $3K | |
| C2617 | Stent, non-coronary, temporary, without delivery system | <1% | 46 | $2K |
| 73130 | <1% | 144 | $2K | |
| 97803 | <1% | 48 | $2K | |
| 95819 | <1% | 27 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 50 | $1K |
| 82550 | <1% | 476 | $1K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 54 | $1K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 14 | $745.87 |
| 83735 | <1% | 366 | $740.46 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 16 | $667.03 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $570.41 |
| 85027 | <1% | 301 | $485.21 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,228 | $444.00 |
| 86900 | <1% | 92 | $408.27 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 43 | $402.93 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 142 | $387.25 |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 15 | $368.52 |
| 74018 | <1% | 13 | $216.09 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 249 | $198.80 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 442 | $194.25 |
| 85007 | <1% | 137 | $157.71 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,511 | $153.04 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 25 | $146.93 |
| 85610 | <1% | 96 | $119.22 | |
| 87807 | <1% | 26 | $103.37 | |
| 86850 | <1% | 92 | $89.55 | |
| 87420 | <1% | 13 | $76.62 | |
| 94760 | <1% | 167 | $70.62 | |
| 80069 | <1% | 141 | $68.44 | |
| 80061 | Lipid panel | <1% | 43 | $58.48 |
| 84145 | <1% | 13 | $57.70 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 201 | $52.18 |
| 86901 | <1% | 92 | $43.59 | |
| 84703 | <1% | 14 | $37.42 | |
| 74022 | <1% | 13 | $26.78 | |
| 87077 | <1% | 12 | $23.20 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,844 | $0.98 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 1,132 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 154 | $0.00 |
| 88312 | 0% | 12 | $0.00 | |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 22 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 16 | $0.00 |
| 76937 | 0% | 13 | $0.00 | |
| 87186 | 0% | 15 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 418 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 13 | $0.00 |
| A9270 | Non-covered item or service | 0% | 587 | $0.00 |
| 86140 | 0% | 33 | $0.00 | |
| C1769 | Guide wire | 0% | 32 | $0.00 |
| 88304 | 0% | 26 | $0.00 | |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 49 | $0.00 |
| 87088 | 0% | 15 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 16 | $0.00 |
| 83615 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWHITLOCK, GREGORY (VP FINANCE/IT)
| Provider | Location | Paid |
|---|---|---|
| Maury Regional Hospital Marshall Medical Center | Lewisburg, TN | $5.52M |
| Maury Regional Hospital | Hohenwald, TN | $4.36M |
| Maury Regional Hospital Marshall Medical Center | Columbia, TN | $1.50M |
| Maury Regional Hospital | Waynesboro, TN | $1.49M |
| Maury Regional Hospital Marshall Medical Center | Columbia, TN | $497K |
| Maury Regional Hospital Marshall Medical Center | Columbia, TN | $214K |
| Maury Regional Hospital Marshall Medical Center | Mt Pleasant, TN | $148K |
| Maury Regional Hospital | Columbia, TN | $91K |
| Maury Regional Hospital Marshall Medical Center | Columbia, TN | $37K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.